Chemed Cash Flow from Operating Activities 2012-2026 | CHE
Chemed annual/quarterly cash flow from operating activities history and growth rate from 2012 to 2026. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Chemed cash flow from operating activities for the quarter ending March 31, 2026 was $0.255B, a 0.85% increase year-over-year.
- Chemed cash flow from operating activities for the twelve months ending March 31, 2026 was $0.876B, a 5.65% increase year-over-year.
- Chemed annual cash flow from operating activities for 2024 was $0.417B, a 26.4% increase from 2023.
- Chemed annual cash flow from operating activities for 2023 was $0.33B, a 6.59% increase from 2022.
- Chemed annual cash flow from operating activities for 2022 was $0.31B, a 0.42% increase from 2021.
|
Chemed Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $417 |
| 2023 | $330 |
| 2022 | $310 |
| 2021 | $309 |
| 2020 | $489 |
| 2019 | $301 |
| 2018 | $287 |
| 2017 | $162 |
| 2016 | $135 |
| 2015 | $172 |
| 2014 | $110 |
| 2013 | $151 |
| 2012 | $132 |
| 2011 | $174 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |